Bensedin 10mg Tablets (Diazepam) – Galenika | Prescription Benzodiazepine

Overview & Active Component

Bensedin 10mg contains the active pharmaceutical ingredient diazepam, a long-acting classical benzodiazepine. Manufactured by Galenika a.d., Bensedin is an internationally recognized pharmaceutical brand utilized for central nervous system modulation. Diazepam functions as a positive allosteric modulator at central $\text{GABA}_\text{A}$ receptor complexes, enhancing the opening frequency of chloride channels in the presence of gamma-aminobutyric acid ($\text{GABA}$). This neuronal hyperpolarization suppresses excessive central neural excitability, yielding marked sedation, anxiolysis, and muscular relaxation.

Primary Indications

• Severe & Acute Anxiety: Short-term intervention (recommended duration: 2 to 4 weeks maximum) for disabling anxiety, tension states, and severe psychomotor agitation.

• Musculoskeletal Spasms & Spasticity: Symptomatic alleviation of reflex muscle contractures arising from local trauma, inflammatory joint pathology, or chronic neurological upper motor neuron disorders (e.g., spinal injury, cerebral palsy).

• Acute Alcohol Withdrawal Syndrome: Inpatient or monitored outpatient treatment targeting autonomic hyperactivity, severe tremors, acute agitation, and prevention of delirium tremens.

• Adjunctive Seizure Management: Secondary oral maintenance therapy in specific refractory convulsive disorders.

Product Specifications

• Brand Name: Bensedin

• Active Substance: Diazepam ($10\text{ mg}$ per tablet)

• Manufacturer: Galenika a.d.

• Packaging: Box containing blister packaging (30 tablets total: 3 strips of 10 tablets)

• Dosage Form: Oral solid tablet

• Pharmacological Classification: Centrally Acting Anxiolytic / Benzodiazepine / Skeletal Muscle Relaxant

• Regulatory Classification: Prescription-Only Medicine (POM); Schedule IV Controlled Drug

• Pharmacokinetic Profile: Rapid oral absorption reaching peak plasma concentration ($T_{\max}$) within 30 to 90 minutes. Long elimination half-life ($20\text{ to }50\text{ hours}$ for parent diazepam; extending up to 100 hours for active metabolite $N\text{-desmethyldiazepam}$).

• Storage Instructions: Store in the original packaging below 25°C, protected from light, moisture, and extreme heat. Keep out of reach and sight of children.

Clinical Cautions, Warnings & Contraindications

• Dependence & Tolerance: Regular, sustained administration can cause marked physical and psychological dependence. Therapy should always be restricted to the lowest therapeutic dose for the shortest duration necessary.

• Gradual Discontinuation: Never stop Bensedin abruptly following continuous use. Stepwise dosage reduction under clinical supervision is mandatory to prevent severe rebound symptoms, psychotic episodes, or withdrawal seizures.

• CNS & Respiratory Depression Warning: Concurrent use with alcohol, opioid analgesics, barbiturates, or other sedatives creates a synergistic depressant effect, significantly elevating the risk of profound sedation, respiratory arrest, coma, and fatality.

• Contraindications: Severe chronic respiratory insufficiency, sleep apnoea syndrome, severe hepatic failure, myasthenia gravis, and known hypersensitivity to diazepam or other benzodiazepines.

• Psychomotor Impairment: Drowsiness, slowed reaction times, and muscle weakness are frequent. Operating motor vehicles or complex machinery is strictly contraindicated while under therapy.